Soya Protein for Weight Control
Are there any side effects or interactions?
Soya products and cooked soybeans
are safe at a wide range of intakes. However, a small percentage of people have allergies to soybeans and thus should avoid soya products.
Soya isoflavones have been reported to reduce thyroid function in some people.6
A preliminary trial of soya supplementation among healthy Japanese, found that 30 grams (about
one ounce) per day of soybeans for three months, led to a slight reduction in the hormone that
stimulates the thyroid gland.7 Some participants complained of malaise, constipation, sleepiness, and even goitre. These symptoms resolved within a month of discontinuing
soya supplements. However, a variety of soya products have been shown to either cause an
increase in thyroid function8 or produce no change in thyroid
function.9 The clinical importance of interactions between soya and thyroid
function remains unclear. However, in infants with congenital hypothyroidism, soya formula must not be added, nor
removed from the diet, without consultation with a physician, because ingestion of soya may
interfere with the absorption of thyroid medication.10
Most research, including animal studies, report
anticancer effects of soya extracts,11 though occasional animal studies have
reported cancer-enhancing effects.12 The findings of several recent studies suggest
that consuming soya might, under some circumstances, increase the risk of breast cancer. When ovaries have been removed from
animals—a situation related to the condition of women who have had a total
hysterectomy—dietary genistein has been reported to increase the proliferation
of breast cancer cells.13 When pregnant rats were given genistein injections, their
female offspring were reported to be at greater risk of breast cancer.14
Although premenopausal women have shown decreases in oestrogen levels in response to soya,15
16 pro-oestrogenic effects have also been reported.17 When pre-menopausal
women were given soya isoflavones, an increase in breast secretions resulted—an effect
thought to elevate the risk of breast cancer.18 In yet another trial,
healthy breast cells from women previously given soya supplements containing isoflavones
showed an increase in proliferation rates—an effect that might also increase
the risk of breast cancer.19
Of 154 healthy postmenopausal women who received 150 mg of soya isoflavones per day for
five years, 3.9% developed an abnormal proliferation of the tissue that lines the uterus
(endometrial hyperplasia). In contrast, none of 144 women who received a placebo developed
uterine hyperplasia.20 Although no case of uterine cancer was diagnosed during the
study, endometrial hyperplasia is a potential forerunner of uterine cancer. The amount of
isoflavones used in this study is two to three times as much as that used in many other
studies. Nevertheless, the possibility exists that long-term use of isoflavones could cause
uterine hyperplasia, and women taking isoflavones should be monitored appropriately by their
doctor.
Soya contains a compound called phytic acid, which can
interfere with mineral absorption.
Are there any drug
interactions?
Certain medicines may interact with soya. Refer to drug
interactions for a list of those medicines.
References
1. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens
in obesity and diabetes. Am J Clin Nutr 2002;76:1191–201 [review].
2. Allison DB, Gadbury G, Schwartz LG, et al. A novel soy-based meal
replacement formula for weight loss among obese individuals: a randomized controlled clinical
trial. Eur J Clin Nutr 2003;57:514–22.
3. Bosello O, Cominancini L, Zocca I, et al. Short- and long-term effects
of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins
of obese subjects. Ann Nutr Metab 1988; 32:206–14.
4. Yamashita T, Sasahara T, Pomeroy SE, et al. Arterial compliance, blood
pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally
with a meat-based diet and a plant-based diet. Metabolism 1998;47:1308–14.
5. Jenkins DJ, Wolever TM, Spiller G, et al. Hypocholesterolemic effect
of vegetable protein in a hypocaloric diet. Atherosclerosis 1989;78:99–107.
6. Divi RL, Chang HC, Doerge DR. Antithyroid isoflavones from soybean.
Biochem Pharmacol 1997;54:1087–96.
7. Ishizuki Y, Hirooka Y, Murata Y, Togashi K. [The effects on the
thyroid gland of soybeans administered experimentally in healthy subjects.] Nippon
Naibunpi Gakkai Zasshi 1991;67:622–9. [in Japanese].
8. Forsythe WA. Soy Protein, thyroid regulation and cholesterol
metabolism. Forsythe WA. Soy protein, thyroid regulation and cholesterol metabolism. J
Nutr 1995;125:619S–23S.
9. Bennink MR, Mayle JE, Bourquin LD, Thiagarajan D. Evaluation of soy
protein in risk reduction for colon cancer and cardiovascular disease: Preliminary results.
Second International Symposium on the Role of Soy in Preventing and Treating Chronic
Disease. September 15–18, 1996. Brussels, Belgium.
10. Jabbar MA, Larrea J, Shaw RA. Abnormal thyroid function tests in
infants with congenital hypothyroidism: the influence of soy-based formula. J Am Coll
Nutr 1997;16:280–2.
11. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer
risk: a review of the in vitro and in vivo data. Nutr Cancer
1994;21:113–31.
12. Rao CV, Wang C-X, Simi B, et al. Enhancement of experimental colon
cancer by genistein. Cancer Res 1997;57:3717–22.
13. Barnes S. The chemopreventive properties of soy isoflavonoids in
animal models of breast cancer. Breast Cancer Res Treat 1997;46:169–79
[review].
14. Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to
genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat
offspring. Oncol Rep 1999;6:1089–95.
15. Lu L-JW, Anderson KE, Grady JJ, Nagamani M. Effects of soya
consumption for one month on steroid hormones in premenopausal women: implications for breast
cancer risk reduction. Cancer Epidemiol Biomarkers Prev 1996;5:63–70.
16. Nagata C, Takatsuka N, Inaba S, et al. Effect of soymilk consumption
on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst
1998;90:1830–5.
17. Hargreaves DNF, Potten CS, Harding C, et al. Two-week dietary soy
supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol
Metab 1999;84:4017–24.
18. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy
protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol
Biomarkers Prev 1996;5:785–94.
19. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of
soy-protein supplementation on epithelial proliferation in the histologically normal human
breast. Am J Clin Nutr 1998;68(suppl):1431S–6S.
20. Unfer V, Casini ML, Costabile L, et al. Endometrial effects of
long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.
Fertil Steril 2004;82:145–8.